A study of the web as DTC drug marketing agent.
The growth of direct-to-consumer (DTC) marketing of pharmaceuticals in the USA has spawned the generation of web sites for consumer information and discussion, related to specific medical conditions and the efficacy of specific drugs. In such an environment consumers often find and act upon health information of variable quality, with little input from health professionals. Some health policy analysts argue that the emergence of such consumer "drug networks" will lead to unnecessary expenditure of money on prescription drugs, as consumers see ads and then demand that their providers prescribe that drug. Others say that an intelligent consumer will be able to research the information and narrow down a drug that will likely work for them personally, rather than having the provider "experiment" with different medications. There exist few cross-disciplinary evaluative frameworks for assessing such health information, especially within commercial search engines. This study serves as an exploratory technology assessment that examines the prevalence of web-based DTC for a popular prescription drug and the impact on healthcare consumers.
Penn State Center for Technology Assessment, PO Box 1154, State College, PA 16801, USA. danlor467@yahoo.com
Daniel
D
Lorence
Rick
R
Churchill
D002170:Canada; D003256:Community Participation; D004345:Drug Industry; D006801:Humans; D016247:Information Storage and Retrieval / Q000379:methods; D020407:Internet; D040541:Marketing / Q000379:methods*; D014481:United States